Cargando…
Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
BACKGROUND AND AIMS: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNAR1) have been associated with the susceptibility to and the outcome of chronic hepatitis B virus (HBV) infection. However, the impact of these polymorphisms in the transcriptome of the HBV-associated...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911724/ https://www.ncbi.nlm.nih.gov/pubmed/29713327 http://dx.doi.org/10.3389/fimmu.2018.00777 |
_version_ | 1783316262198181888 |
---|---|
author | Karamitros, Timokratis Papatheodoridis, George Paraskevis, Dimitrios Hatzakis, Angelos Mbisa, Jean L. Georgopoulou, Urania Klenerman, Paul Magiorkinis, Gkikas |
author_facet | Karamitros, Timokratis Papatheodoridis, George Paraskevis, Dimitrios Hatzakis, Angelos Mbisa, Jean L. Georgopoulou, Urania Klenerman, Paul Magiorkinis, Gkikas |
author_sort | Karamitros, Timokratis |
collection | PubMed |
description | BACKGROUND AND AIMS: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNAR1) have been associated with the susceptibility to and the outcome of chronic hepatitis B virus (HBV) infection. However, the impact of these polymorphisms in the transcriptome of the HBV-associated hepatocellular carcinoma (HCC) remains largely unexplored. METHODS: Using whole-genome and exome sequencing data from The Cancer Genome Atlas project, we characterized three single-nucleotide polymorphisms (SNPs: −568G/C, −408C/T, −3C/T) and one variable number tandem repeat [VNTR: −77(GT)n] within the IFNAR1 promoter sequence in 49 HCC patients. RNAseq data from 10 genotyped HCC samples were grouped according to their −77VNTR or −3SNP genotype to evaluate the impact of these polymorphisms on the differential expression on the HCC transcriptome. RESULTS: There is a fourfold higher impact of the −77VNTR on the HCC transcriptome compared to the −3SNP (q < 0.1, p < 0.001). The expression of the primary IFNAR1 transcript is not affected by these polymorphisms but a secondary, HCC-specific transcript is expressed only in homozygous −77VNTR ≤8/≤8(GT)n samples (p < 0.05). At the same time, patients carrying at least one −77VNTR >8(GT) allele, presented a strong upregulation of the fibronectin-1 (FN-1) gene, which has been associated with the development of HCC. Gene Ontology and pathway enrichment analysis of the differentially expressed genes revealed a strong disruption of the PI3K–AKT signaling pathway, which can be partially triggered by the extracellular matrix FN-1. CONCLUSION: The IFNAR-1 promoter polymorphisms are not involved in the expression levels of the main IFNAR-1 transcript. The −77VNTR has a regulatory role on the expression of a secondary, truncated, HCC-specific transcript, which in turn coincides with disruptions in cancer-associated pathways and in FN-1 expression modifications. |
format | Online Article Text |
id | pubmed-5911724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59117242018-04-30 Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma Karamitros, Timokratis Papatheodoridis, George Paraskevis, Dimitrios Hatzakis, Angelos Mbisa, Jean L. Georgopoulou, Urania Klenerman, Paul Magiorkinis, Gkikas Front Immunol Immunology BACKGROUND AND AIMS: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNAR1) have been associated with the susceptibility to and the outcome of chronic hepatitis B virus (HBV) infection. However, the impact of these polymorphisms in the transcriptome of the HBV-associated hepatocellular carcinoma (HCC) remains largely unexplored. METHODS: Using whole-genome and exome sequencing data from The Cancer Genome Atlas project, we characterized three single-nucleotide polymorphisms (SNPs: −568G/C, −408C/T, −3C/T) and one variable number tandem repeat [VNTR: −77(GT)n] within the IFNAR1 promoter sequence in 49 HCC patients. RNAseq data from 10 genotyped HCC samples were grouped according to their −77VNTR or −3SNP genotype to evaluate the impact of these polymorphisms on the differential expression on the HCC transcriptome. RESULTS: There is a fourfold higher impact of the −77VNTR on the HCC transcriptome compared to the −3SNP (q < 0.1, p < 0.001). The expression of the primary IFNAR1 transcript is not affected by these polymorphisms but a secondary, HCC-specific transcript is expressed only in homozygous −77VNTR ≤8/≤8(GT)n samples (p < 0.05). At the same time, patients carrying at least one −77VNTR >8(GT) allele, presented a strong upregulation of the fibronectin-1 (FN-1) gene, which has been associated with the development of HCC. Gene Ontology and pathway enrichment analysis of the differentially expressed genes revealed a strong disruption of the PI3K–AKT signaling pathway, which can be partially triggered by the extracellular matrix FN-1. CONCLUSION: The IFNAR-1 promoter polymorphisms are not involved in the expression levels of the main IFNAR-1 transcript. The −77VNTR has a regulatory role on the expression of a secondary, truncated, HCC-specific transcript, which in turn coincides with disruptions in cancer-associated pathways and in FN-1 expression modifications. Frontiers Media S.A. 2018-04-16 /pmc/articles/PMC5911724/ /pubmed/29713327 http://dx.doi.org/10.3389/fimmu.2018.00777 Text en Copyright © 2018 Karamitros, Papatheodoridis, Paraskevis, Hatzakis, Mbisa, Georgopoulou, Klenerman and Magiorkinis. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Karamitros, Timokratis Papatheodoridis, George Paraskevis, Dimitrios Hatzakis, Angelos Mbisa, Jean L. Georgopoulou, Urania Klenerman, Paul Magiorkinis, Gkikas Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma |
title | Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma |
title_full | Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma |
title_fullStr | Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma |
title_full_unstemmed | Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma |
title_short | Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma |
title_sort | impact of interferon-α receptor-1 promoter polymorphisms on the transcriptome of the hepatitis b virus-associated hepatocellular carcinoma |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911724/ https://www.ncbi.nlm.nih.gov/pubmed/29713327 http://dx.doi.org/10.3389/fimmu.2018.00777 |
work_keys_str_mv | AT karamitrostimokratis impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma AT papatheodoridisgeorge impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma AT paraskevisdimitrios impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma AT hatzakisangelos impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma AT mbisajeanl impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma AT georgopoulouurania impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma AT klenermanpaul impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma AT magiorkinisgkikas impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma |